J
Jim Yee
Researcher at Cornell University
Publications - 17
Citations - 2258
Jim Yee is an academic researcher from Cornell University. The author has contributed to research in topics: Antibody & Vaccination. The author has an hindex of 7, co-authored 13 publications receiving 731 citations. Previous affiliations of Jim Yee include Rockefeller University & NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
Evolution of antibody immunity to SARS-CoV-2.
Christian Gaebler,Zijun Wang,Julio C. C. Lorenzi,Frauke Muecksch,Shlomo Finkin,Minami Tokuyama,Alice Cho,Mila Jankovic,Dennis Schaefer-Babajew,Thiago Y. Oliveira,Melissa Cipolla,Charlotte Viant,Christopher O. Barnes,Yaron Bram,Gaëlle Breton,Thomas Hagglof,Pilar Mendoza,Arlene Hurley,Martina Turroja,Kristie Gordon,Katrina G. Millard,Victor A. Ramos,Fabian Schmidt,Yiska Weisblum,Divya Jha,Michael Tankelevich,Gustavo Martinez-Delgado,Jim Yee,Roshni Patel,Juan Dizon,Cecille Unson-O'Brien,Irina Shimeliovich,Davide F. Robbiani,Zhen Zhao,Anna Gazumyan,Robert E. Schwartz,Theodora Hatziioannou,Pamela J. Bjorkman,Saurabh Mehandru,Paul D. Bieniasz,Paul D. Bieniasz,Marina Caskey,Michel C. Nussenzweig,Michel C. Nussenzweig +43 more
TL;DR: In this article, the authors report on the humoral memory response in a cohort of 87 individuals assessed at 1.3 and 6.2 months after infection with SARS-CoV-2.
Journal ArticleDOI
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
Zijun Wang,Frauke Muecksch,Dennis Schaefer-Babajew,Shlomo Finkin,Charlotte Viant,Christian Gaebler,Hans Heinrich Hoffmann,Christopher O. Barnes,Melissa Cipolla,Victor A. Ramos,Thiago Y. Oliveira,Alice Cho,Fabian Schmidt,Justin Da Silva,Eva Bednarski,Lauren C. Aguado,Jim Yee,Mridushi Daga,Martina Turroja,Katrina G. Millard,Mila Jankovic,Anna Gazumyan,Anna Gazumyan,Zhen Zhao,Charles M. Rice,Paul D. Bieniasz,Paul D. Bieniasz,Marina Caskey,Theodora Hatziioannou,Michel C. Nussenzweig,Michel C. Nussenzweig +30 more
TL;DR: In the absence of vaccination, antibody reactivity to the receptor binding domain (RBD) of SARS-CoV-2, neutralizing activity and the number of RBD-specific memory B cells remain relatively stable between 6 and 12 months after infection.
Posted ContentDOI
Evolution of Antibody Immunity to SARS-CoV-2
Christian Gaebler,Zijun Wang,Julio C. C. Lorenzi,Frauke Muecksch,Shlomo Finkin,Minami Tokuyama,Alice Cho,Mila Jankovic,Dennis Schaefer-Babajew,Thiago Y. Oliveira,Melissa Cipolla,Charlotte Viant,Christopher O. Barnes,Arlene Hurley,Martina Turroja,Kristie Gordon,Katrina G. Millard,Victor A. Ramos,Fabian Schmidt,Yiska Weisblum,Divya Jha,Michael Tankelevich,Jim Yee,Irina Shimeliovich,Davide F. Robbiani,Zhen Zhao,Anna Gazumyan,Theodora Hatziioannou,Pamela J. Bjorkman,Saurabh Mehandru,Paul D. Bieniasz,Marina Caskey,Michel C. Nussenzweig,Thomas Hagglof,Robert E. Schwartz,Yaron Bram,Gustavo Martinez-Delgado,Pilar Mendoza,Gaëlle Breton,Juan Dizon,Cecille Unson-O'Brien,Roshni Patel +41 more
TL;DR: The memory B cell response to SARS-CoV-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence, and the antibodies they express have greater somatic hypermutation, increased potency and resistance to RBD mutations, indicative of continued evolution of the humoral response.
Journal ArticleDOI
Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood.
Malavika Prabhu,Elisabeth A. Murphy,Ashley Sukhu,Jim Yee,Sunidhi Singh,Dorothy Eng,Zhen Zhao,Laura E. Riley,Yawei J. Yang +8 more
TL;DR: In this article, the authors excluded pregnant women from initial clinical trials for coronavirus disease 2019 (COVID-19) vaccines and thus, the understanding of the immunologic response to vaccination in pregnancy and the transplacental transfer of maternal antibodies is limited.
Posted ContentDOI
Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year
Zijun Wang,Frauke Muecksch,Dennis Schaefer-Babajew,Shlomo Finkin,Charlotte Viant,Christian Gaebler,Hans-Heinrich Hoffmann,Christopher O. Barnes,Melissa Cipolla,Victor A. Ramos,Thiago Y. Oliveira,Alice Cho,Fabian Schmidt,Justin Da Silva,Eva Bednarski,Lauren C. Aguado,Jim Yee,Mridushi Daga,Martina Turroja,Katrina G. Millard,Mila Jankovic,Anna Gazumyan,Anna Gazumyan,Zhen Zhao,Charles M. Rice,Paul D. Bieniasz,Paul D. Bieniasz,Marina Caskey,Theodora Hatziioannou,Michel C. Nussenzweig,Michel C. Nussenzweig +30 more
TL;DR: In the absence of vaccination antibody reactivity to the receptor binding domain (RBD) of SARS-CoV-2, neutralizing activity and the number of RBD-specific memory B cells remain relatively stable from 6 to 12 months as discussed by the authors.